nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP2C19—Teniposide—lymphatic system cancer	0.144	0.219	CbGbCtD
Loratadine—CYP2C9—Teniposide—lymphatic system cancer	0.12	0.182	CbGbCtD
Loratadine—ABCB1—Mitoxantrone—lymphatic system cancer	0.0811	0.124	CbGbCtD
Loratadine—CYP3A4—Cytarabine—lymphatic system cancer	0.0706	0.108	CbGbCtD
Loratadine—CYP3A4—Teniposide—lymphatic system cancer	0.0695	0.106	CbGbCtD
Loratadine—Menstruation delayed—Mechlorethamine—lymphatic system cancer	0.0572	0.167	CcSEcCtD
Loratadine—ABCB1—Vincristine—lymphatic system cancer	0.0558	0.0851	CbGbCtD
Loratadine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0486	0.0741	CbGbCtD
Loratadine—ABCB1—Methotrexate—lymphatic system cancer	0.0338	0.0515	CbGbCtD
Loratadine—CYP3A4—Vincristine—lymphatic system cancer	0.0335	0.051	CbGbCtD
Loratadine—Taste altered—Mitoxantrone—lymphatic system cancer	0.0122	0.0355	CcSEcCtD
Loratadine—Urine color abnormal—Mitoxantrone—lymphatic system cancer	0.0117	0.0342	CcSEcCtD
Loratadine—Blister—Mechlorethamine—lymphatic system cancer	0.00996	0.029	CcSEcCtD
Loratadine—Chromaturia—Mitoxantrone—lymphatic system cancer	0.00775	0.0225	CcSEcCtD
Loratadine—Stomach ache—Mitoxantrone—lymphatic system cancer	0.00651	0.0189	CcSEcCtD
Loratadine—Dermatitis bullous—Mechlorethamine—lymphatic system cancer	0.00545	0.0159	CcSEcCtD
Loratadine—Depression—Mechlorethamine—lymphatic system cancer	0.004	0.0116	CcSEcCtD
Loratadine—Tinnitus—Mechlorethamine—lymphatic system cancer	0.00336	0.00978	CcSEcCtD
Loratadine—Drug interaction—Carmustine—lymphatic system cancer	0.00321	0.00933	CcSEcCtD
Loratadine—Alopecia—Mechlorethamine—lymphatic system cancer	0.00319	0.00927	CcSEcCtD
Loratadine—Viral infection—Mitoxantrone—lymphatic system cancer	0.00306	0.00891	CcSEcCtD
Loratadine—Drug interaction—Vincristine—lymphatic system cancer	0.00306	0.00891	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.00265	0.00772	CcSEcCtD
Loratadine—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00256	0.00745	CcSEcCtD
Loratadine—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00249	0.00724	CcSEcCtD
Loratadine—Epistaxis—Fludarabine—lymphatic system cancer	0.00245	0.00714	CcSEcCtD
Loratadine—Arrhythmia—Teniposide—lymphatic system cancer	0.00237	0.00691	CcSEcCtD
Loratadine—Alopecia—Teniposide—lymphatic system cancer	0.00235	0.00683	CcSEcCtD
Loratadine—Pharyngitis—Fludarabine—lymphatic system cancer	0.00232	0.00674	CcSEcCtD
Loratadine—Agitation—Teniposide—lymphatic system cancer	0.00213	0.00618	CcSEcCtD
Loratadine—Arrhythmia—Fludarabine—lymphatic system cancer	0.00209	0.00607	CcSEcCtD
Loratadine—Alopecia—Fludarabine—lymphatic system cancer	0.00206	0.006	CcSEcCtD
Loratadine—Hypertension—Teniposide—lymphatic system cancer	0.002	0.00581	CcSEcCtD
Loratadine—Chest pain—Teniposide—lymphatic system cancer	0.00197	0.00573	CcSEcCtD
Loratadine—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00189	0.00549	CcSEcCtD
Loratadine—Agitation—Fludarabine—lymphatic system cancer	0.00187	0.00544	CcSEcCtD
Loratadine—Tachycardia—Teniposide—lymphatic system cancer	0.00184	0.00536	CcSEcCtD
Loratadine—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.00183	0.00534	CcSEcCtD
Loratadine—Malaise—Fludarabine—lymphatic system cancer	0.00183	0.00533	CcSEcCtD
Loratadine—Cough—Fludarabine—lymphatic system cancer	0.00177	0.00516	CcSEcCtD
Loratadine—Hypotension—Teniposide—lymphatic system cancer	0.00176	0.00513	CcSEcCtD
Loratadine—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00175	0.0051	CcSEcCtD
Loratadine—Myalgia—Fludarabine—lymphatic system cancer	0.00173	0.00504	CcSEcCtD
Loratadine—Discomfort—Fludarabine—lymphatic system cancer	0.00171	0.00498	CcSEcCtD
Loratadine—Depression—Carmustine—lymphatic system cancer	0.00166	0.00483	CcSEcCtD
Loratadine—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00166	0.00483	CcSEcCtD
Loratadine—Vomiting—Mechlorethamine—lymphatic system cancer	0.00163	0.00474	CcSEcCtD
Loratadine—Nervous system disorder—Fludarabine—lymphatic system cancer	0.00163	0.00473	CcSEcCtD
Loratadine—Rash—Mechlorethamine—lymphatic system cancer	0.00161	0.0047	CcSEcCtD
Loratadine—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00161	0.00469	CcSEcCtD
Loratadine—Depression—Vincristine—lymphatic system cancer	0.00159	0.00461	CcSEcCtD
Loratadine—Feeling abnormal—Teniposide—lymphatic system cancer	0.00156	0.00453	CcSEcCtD
Loratadine—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00155	0.0045	CcSEcCtD
Loratadine—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00154	0.00449	CcSEcCtD
Loratadine—Nausea—Mechlorethamine—lymphatic system cancer	0.00152	0.00443	CcSEcCtD
Loratadine—Alopecia—Bleomycin—lymphatic system cancer	0.00151	0.0044	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00151	0.0044	CcSEcCtD
Loratadine—Abdominal pain—Teniposide—lymphatic system cancer	0.00149	0.00434	CcSEcCtD
Loratadine—Body temperature increased—Teniposide—lymphatic system cancer	0.00149	0.00434	CcSEcCtD
Loratadine—Paraesthesia—Fludarabine—lymphatic system cancer	0.00149	0.00433	CcSEcCtD
Loratadine—Dyspepsia—Fludarabine—lymphatic system cancer	0.00146	0.00425	CcSEcCtD
Loratadine—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00143	0.00417	CcSEcCtD
Loratadine—Fatigue—Fludarabine—lymphatic system cancer	0.00143	0.00416	CcSEcCtD
Loratadine—Pain—Fludarabine—lymphatic system cancer	0.00142	0.00413	CcSEcCtD
Loratadine—Constipation—Fludarabine—lymphatic system cancer	0.00142	0.00413	CcSEcCtD
Loratadine—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00138	0.00402	CcSEcCtD
Loratadine—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00138	0.00401	CcSEcCtD
Loratadine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00137	0.00398	CcSEcCtD
Loratadine—Asthenia—Teniposide—lymphatic system cancer	0.00135	0.00394	CcSEcCtD
Loratadine—Malaise—Bleomycin—lymphatic system cancer	0.00134	0.00391	CcSEcCtD
Loratadine—Arrhythmia—Carmustine—lymphatic system cancer	0.00134	0.00388	CcSEcCtD
Loratadine—Alopecia—Carmustine—lymphatic system cancer	0.00132	0.00384	CcSEcCtD
Loratadine—Body temperature increased—Fludarabine—lymphatic system cancer	0.00131	0.00382	CcSEcCtD
Loratadine—Cough—Bleomycin—lymphatic system cancer	0.0013	0.00378	CcSEcCtD
Loratadine—Diarrhoea—Teniposide—lymphatic system cancer	0.00129	0.00376	CcSEcCtD
Loratadine—Chest pain—Bleomycin—lymphatic system cancer	0.00127	0.00369	CcSEcCtD
Loratadine—Myalgia—Bleomycin—lymphatic system cancer	0.00127	0.00369	CcSEcCtD
Loratadine—Alopecia—Vincristine—lymphatic system cancer	0.00126	0.00367	CcSEcCtD
Loratadine—Discomfort—Bleomycin—lymphatic system cancer	0.00125	0.00365	CcSEcCtD
Loratadine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00124	0.00361	CcSEcCtD
Loratadine—Alopecia—Mitoxantrone—lymphatic system cancer	0.00123	0.00357	CcSEcCtD
Loratadine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00122	0.00354	CcSEcCtD
Loratadine—Vomiting—Teniposide—lymphatic system cancer	0.0012	0.00349	CcSEcCtD
Loratadine—Agitation—Carmustine—lymphatic system cancer	0.0012	0.00348	CcSEcCtD
Loratadine—Asthenia—Fludarabine—lymphatic system cancer	0.00119	0.00346	CcSEcCtD
Loratadine—Rash—Teniposide—lymphatic system cancer	0.00119	0.00346	CcSEcCtD
Loratadine—Dermatitis—Teniposide—lymphatic system cancer	0.00119	0.00346	CcSEcCtD
Loratadine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00118	0.00345	CcSEcCtD
Loratadine—Headache—Teniposide—lymphatic system cancer	0.00118	0.00344	CcSEcCtD
Loratadine—Agitation—Vincristine—lymphatic system cancer	0.00114	0.00332	CcSEcCtD
Loratadine—Hypotension—Bleomycin—lymphatic system cancer	0.00114	0.00331	CcSEcCtD
Loratadine—Diarrhoea—Fludarabine—lymphatic system cancer	0.00114	0.0033	CcSEcCtD
Loratadine—Hypertension—Carmustine—lymphatic system cancer	0.00112	0.00327	CcSEcCtD
Loratadine—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00112	0.00327	CcSEcCtD
Loratadine—Nausea—Teniposide—lymphatic system cancer	0.00112	0.00326	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00111	0.00322	CcSEcCtD
Loratadine—Myalgia—Carmustine—lymphatic system cancer	0.00111	0.00322	CcSEcCtD
Loratadine—Chest pain—Carmustine—lymphatic system cancer	0.00111	0.00322	CcSEcCtD
Loratadine—Paraesthesia—Bleomycin—lymphatic system cancer	0.00109	0.00318	CcSEcCtD
Loratadine—Malaise—Mitoxantrone—lymphatic system cancer	0.00109	0.00317	CcSEcCtD
Loratadine—Hypertension—Vincristine—lymphatic system cancer	0.00107	0.00312	CcSEcCtD
Loratadine—Myalgia—Vincristine—lymphatic system cancer	0.00106	0.00308	CcSEcCtD
Loratadine—Cough—Mitoxantrone—lymphatic system cancer	0.00106	0.00307	CcSEcCtD
Loratadine—Vomiting—Fludarabine—lymphatic system cancer	0.00106	0.00307	CcSEcCtD
Loratadine—Rash—Fludarabine—lymphatic system cancer	0.00105	0.00304	CcSEcCtD
Loratadine—Dermatitis—Fludarabine—lymphatic system cancer	0.00105	0.00304	CcSEcCtD
Loratadine—Hypertension—Mitoxantrone—lymphatic system cancer	0.00104	0.00304	CcSEcCtD
Loratadine—Pain—Bleomycin—lymphatic system cancer	0.00104	0.00303	CcSEcCtD
Loratadine—Headache—Fludarabine—lymphatic system cancer	0.00104	0.00302	CcSEcCtD
Loratadine—Tachycardia—Carmustine—lymphatic system cancer	0.00104	0.00302	CcSEcCtD
Loratadine—Myalgia—Mitoxantrone—lymphatic system cancer	0.00103	0.003	CcSEcCtD
Loratadine—Chest pain—Mitoxantrone—lymphatic system cancer	0.00103	0.003	CcSEcCtD
Loratadine—Lethargy—Methotrexate—lymphatic system cancer	0.00102	0.00297	CcSEcCtD
Loratadine—Discomfort—Mitoxantrone—lymphatic system cancer	0.00102	0.00296	CcSEcCtD
Loratadine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00101	0.00295	CcSEcCtD
Loratadine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.001	0.00292	CcSEcCtD
Loratadine—Nervous system disorder—Vincristine—lymphatic system cancer	0.000994	0.00289	CcSEcCtD
Loratadine—Hypotension—Carmustine—lymphatic system cancer	0.000992	0.00289	CcSEcCtD
Loratadine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000987	0.00287	CcSEcCtD
Loratadine—Nausea—Fludarabine—lymphatic system cancer	0.000986	0.00287	CcSEcCtD
Loratadine—Shock—Mitoxantrone—lymphatic system cancer	0.000971	0.00283	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000968	0.00281	CcSEcCtD
Loratadine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000964	0.0028	CcSEcCtD
Loratadine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000962	0.0028	CcSEcCtD
Loratadine—Insomnia—Carmustine—lymphatic system cancer	0.000961	0.00279	CcSEcCtD
Loratadine—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000959	0.00279	CcSEcCtD
Loratadine—Paraesthesia—Carmustine—lymphatic system cancer	0.000954	0.00277	CcSEcCtD
Loratadine—Hypotension—Vincristine—lymphatic system cancer	0.000947	0.00276	CcSEcCtD
Loratadine—Somnolence—Carmustine—lymphatic system cancer	0.000944	0.00275	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000924	0.00269	CcSEcCtD
Loratadine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000923	0.00268	CcSEcCtD
Loratadine—Insomnia—Vincristine—lymphatic system cancer	0.000917	0.00267	CcSEcCtD
Loratadine—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000917	0.00267	CcSEcCtD
Loratadine—Paraesthesia—Vincristine—lymphatic system cancer	0.00091	0.00265	CcSEcCtD
Loratadine—Pain—Carmustine—lymphatic system cancer	0.000908	0.00264	CcSEcCtD
Loratadine—Constipation—Carmustine—lymphatic system cancer	0.000908	0.00264	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.0009	0.00262	CcSEcCtD
Loratadine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000887	0.00258	CcSEcCtD
Loratadine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000878	0.00255	CcSEcCtD
Loratadine—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000875	0.00255	CcSEcCtD
Loratadine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000875	0.00255	CcSEcCtD
Loratadine—Fatigue—Vincristine—lymphatic system cancer	0.000874	0.00254	CcSEcCtD
Loratadine—Asthenia—Bleomycin—lymphatic system cancer	0.000873	0.00254	CcSEcCtD
Loratadine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000869	0.00253	CcSEcCtD
Loratadine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000868	0.00253	CcSEcCtD
Loratadine—Pain—Vincristine—lymphatic system cancer	0.000867	0.00252	CcSEcCtD
Loratadine—Constipation—Vincristine—lymphatic system cancer	0.000867	0.00252	CcSEcCtD
Loratadine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000851	0.00248	CcSEcCtD
Loratadine—Pain—Mitoxantrone—lymphatic system cancer	0.000844	0.00246	CcSEcCtD
Loratadine—Constipation—Mitoxantrone—lymphatic system cancer	0.000844	0.00246	CcSEcCtD
Loratadine—Abdominal pain—Carmustine—lymphatic system cancer	0.00084	0.00244	CcSEcCtD
Loratadine—Body temperature increased—Carmustine—lymphatic system cancer	0.00084	0.00244	CcSEcCtD
Loratadine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000829	0.00241	CcSEcCtD
Loratadine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000814	0.00237	CcSEcCtD
Loratadine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000807	0.00235	CcSEcCtD
Loratadine—Abdominal pain—Vincristine—lymphatic system cancer	0.000801	0.00233	CcSEcCtD
Loratadine—Body temperature increased—Vincristine—lymphatic system cancer	0.000801	0.00233	CcSEcCtD
Loratadine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000781	0.00227	CcSEcCtD
Loratadine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000781	0.00227	CcSEcCtD
Loratadine—Vomiting—Bleomycin—lymphatic system cancer	0.000774	0.00225	CcSEcCtD
Loratadine—Drowsiness—Methotrexate—lymphatic system cancer	0.000771	0.00224	CcSEcCtD
Loratadine—Depression—Methotrexate—lymphatic system cancer	0.000769	0.00224	CcSEcCtD
Loratadine—Rash—Bleomycin—lymphatic system cancer	0.000767	0.00223	CcSEcCtD
Loratadine—Dermatitis—Bleomycin—lymphatic system cancer	0.000766	0.00223	CcSEcCtD
Loratadine—Asthenia—Carmustine—lymphatic system cancer	0.000762	0.00222	CcSEcCtD
Loratadine—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00073	0.00212	CcSEcCtD
Loratadine—Epistaxis—Methotrexate—lymphatic system cancer	0.000728	0.00212	CcSEcCtD
Loratadine—Asthenia—Vincristine—lymphatic system cancer	0.000727	0.00212	CcSEcCtD
Loratadine—Diarrhoea—Carmustine—lymphatic system cancer	0.000727	0.00211	CcSEcCtD
Loratadine—Nausea—Bleomycin—lymphatic system cancer	0.000723	0.0021	CcSEcCtD
Loratadine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000708	0.00206	CcSEcCtD
Loratadine—Dizziness—Carmustine—lymphatic system cancer	0.000702	0.00204	CcSEcCtD
Loratadine—Diarrhoea—Vincristine—lymphatic system cancer	0.000694	0.00202	CcSEcCtD
Loratadine—Pharyngitis—Methotrexate—lymphatic system cancer	0.000687	0.002	CcSEcCtD
Loratadine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000676	0.00197	CcSEcCtD
Loratadine—Vomiting—Carmustine—lymphatic system cancer	0.000675	0.00196	CcSEcCtD
Loratadine—Dizziness—Vincristine—lymphatic system cancer	0.00067	0.00195	CcSEcCtD
Loratadine—Rash—Carmustine—lymphatic system cancer	0.00067	0.00195	CcSEcCtD
Loratadine—Dermatitis—Carmustine—lymphatic system cancer	0.000669	0.00195	CcSEcCtD
Loratadine—Headache—Carmustine—lymphatic system cancer	0.000665	0.00194	CcSEcCtD
Loratadine—Tinnitus—Methotrexate—lymphatic system cancer	0.000646	0.00188	CcSEcCtD
Loratadine—Vomiting—Vincristine—lymphatic system cancer	0.000645	0.00188	CcSEcCtD
Loratadine—Rash—Vincristine—lymphatic system cancer	0.000639	0.00186	CcSEcCtD
Loratadine—Dermatitis—Vincristine—lymphatic system cancer	0.000639	0.00186	CcSEcCtD
Loratadine—Headache—Vincristine—lymphatic system cancer	0.000635	0.00185	CcSEcCtD
Loratadine—Nausea—Carmustine—lymphatic system cancer	0.000631	0.00184	CcSEcCtD
Loratadine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000628	0.00183	CcSEcCtD
Loratadine—Immune system disorder—Methotrexate—lymphatic system cancer	0.000625	0.00182	CcSEcCtD
Loratadine—Rash—Mitoxantrone—lymphatic system cancer	0.000623	0.00181	CcSEcCtD
Loratadine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000622	0.00181	CcSEcCtD
Loratadine—Headache—Mitoxantrone—lymphatic system cancer	0.000619	0.0018	CcSEcCtD
Loratadine—Alopecia—Methotrexate—lymphatic system cancer	0.000612	0.00178	CcSEcCtD
Loratadine—Nausea—Vincristine—lymphatic system cancer	0.000602	0.00175	CcSEcCtD
Loratadine—Dysgeusia—Methotrexate—lymphatic system cancer	0.00059	0.00172	CcSEcCtD
Loratadine—Nausea—Mitoxantrone—lymphatic system cancer	0.000586	0.00171	CcSEcCtD
Loratadine—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000559	0.00163	CcSEcCtD
Loratadine—Malaise—Methotrexate—lymphatic system cancer	0.000544	0.00158	CcSEcCtD
Loratadine—Cough—Methotrexate—lymphatic system cancer	0.000526	0.00153	CcSEcCtD
Loratadine—Chest pain—Methotrexate—lymphatic system cancer	0.000513	0.00149	CcSEcCtD
Loratadine—Myalgia—Methotrexate—lymphatic system cancer	0.000513	0.00149	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00051	0.00148	CcSEcCtD
Loratadine—Discomfort—Methotrexate—lymphatic system cancer	0.000507	0.00147	CcSEcCtD
Loratadine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000492	0.00143	CcSEcCtD
Loratadine—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000482	0.0014	CcSEcCtD
Loratadine—Skin disorder—Methotrexate—lymphatic system cancer	0.000478	0.00139	CcSEcCtD
Loratadine—Hypotension—Methotrexate—lymphatic system cancer	0.00046	0.00134	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000448	0.0013	CcSEcCtD
Loratadine—Insomnia—Methotrexate—lymphatic system cancer	0.000445	0.00129	CcSEcCtD
Loratadine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000442	0.00128	CcSEcCtD
Loratadine—Somnolence—Methotrexate—lymphatic system cancer	0.000437	0.00127	CcSEcCtD
Loratadine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000433	0.00126	CcSEcCtD
Loratadine—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000425	0.00124	CcSEcCtD
Loratadine—Fatigue—Methotrexate—lymphatic system cancer	0.000424	0.00123	CcSEcCtD
Loratadine—Pain—Methotrexate—lymphatic system cancer	0.000421	0.00122	CcSEcCtD
Loratadine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000405	0.00118	CcSEcCtD
Loratadine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000402	0.00117	CcSEcCtD
Loratadine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000389	0.00113	CcSEcCtD
Loratadine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000389	0.00113	CcSEcCtD
Loratadine—Asthenia—Methotrexate—lymphatic system cancer	0.000353	0.00103	CcSEcCtD
Loratadine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000337	0.000979	CcSEcCtD
Loratadine—Dizziness—Methotrexate—lymphatic system cancer	0.000325	0.000946	CcSEcCtD
Loratadine—Vomiting—Methotrexate—lymphatic system cancer	0.000313	0.00091	CcSEcCtD
Loratadine—Rash—Methotrexate—lymphatic system cancer	0.00031	0.000902	CcSEcCtD
Loratadine—Dermatitis—Methotrexate—lymphatic system cancer	0.00031	0.000901	CcSEcCtD
Loratadine—Headache—Methotrexate—lymphatic system cancer	0.000308	0.000896	CcSEcCtD
Loratadine—Nausea—Methotrexate—lymphatic system cancer	0.000292	0.00085	CcSEcCtD
